$NEO
NEOGENOMICS INC

2022 Q4 Form 10-Q Financial Statement

#000107718322000173 Filed on November 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $138.7M $128.8M
YoY Change 10.32% 6.13%
Cost Of Revenue $81.88M $79.89M
YoY Change 1.75% 7.81%
Gross Profit $56.83M $48.89M
YoY Change 25.56% 3.5%
Gross Profit Margin 40.97% 37.97%
Selling, General & Admin $68.28M $81.09M
YoY Change 1.16% 1.95%
% of Gross Profit 120.16% 165.85%
Research & Development $6.675M $7.312M
YoY Change -21.59% -1.31%
% of Gross Profit 11.75% 14.96%
Depreciation & Amortization $18.07M $17.46M
YoY Change 7.14% 4.88%
% of Gross Profit 31.79% 35.72%
Operating Expenses $78.69M $88.40M
YoY Change -6.86% 1.67%
Operating Profit -$21.87M -$39.51M
YoY Change -44.26% -0.51%
Interest Expense $860.0K $139.0K
YoY Change -150.38% -89.27%
% of Operating Profit
Other Income/Expense, Net -$1.000K $25.00K
YoY Change -99.89% -71.91%
Pretax Income -$25.52M -$39.62M
YoY Change -42.26% 71.01%
Income Tax -$2.837M -$2.772M
% Of Pretax Income
Net Earnings -$22.69M -$36.85M
YoY Change -45.67% 81.11%
Net Earnings / Revenue -16.36% -28.62%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.18 -$296.2K
COMMON SHARES
Basic Shares Outstanding 126.3M shares 124.4M shares
Diluted Shares Outstanding 124.4M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $438.0M $443.5M
YoY Change -15.02% -18.27%
Cash & Equivalents $263.2M $266.1M
Short-Term Investments $174.8M $177.4M
Other Short-Term Assets $8.077M $7.516M
YoY Change -1.37% -52.29%
Inventory $24.28M $23.80M
Prepaid Expenses $15.24M $16.51M
Receivables $119.7M $112.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $605.3M $603.4M
YoY Change -11.18% -15.01%
LONG-TERM ASSETS
Property, Plant & Equipment $102.5M $106.8M
YoY Change -6.36% -0.33%
Goodwill $522.8M $522.8M
YoY Change -0.83% -0.58%
Intangibles $408.3M $416.8M
YoY Change -7.7% -7.53%
Long-Term Investments
YoY Change
Other Assets $5.109M $6.845M
YoY Change -28.72% -5.06%
Total Long-Term Assets $1.135B $1.152B
YoY Change -4.5% -3.7%
TOTAL ASSETS
Total Short-Term Assets $605.3M $603.4M
Total Long-Term Assets $1.135B $1.152B
Total Assets $1.740B $1.756B
YoY Change -6.94% -7.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.51M $13.71M
YoY Change 14.45% -51.96%
Accrued Expenses $61.80M $64.79M
YoY Change -1.89% 12.96%
Deferred Revenue $7.557M $6.386M
YoY Change 45.55% 20.99%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $70.00K $118.0K
YoY Change -93.83% -92.46%
Total Short-Term Liabilities $89.93M $85.00M
YoY Change 3.1% -8.34%
LONG-TERM LIABILITIES
Long-Term Debt $535.3M $534.6M
YoY Change 0.52% 0.5%
Other Long-Term Liabilities $13.06M $14.17M
YoY Change -6.9% -1.84%
Total Long-Term Liabilities $652.1M $657.6M
YoY Change -3.29% -2.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $89.93M $85.00M
Total Long-Term Liabilities $652.1M $657.6M
Total Liabilities $742.0M $742.6M
YoY Change -2.56% -3.45%
SHAREHOLDERS EQUITY
Retained Earnings -$159.1M -$136.4M
YoY Change 972.23% -606.65%
Common Stock $1.161B $1.154B
YoY Change 3.32% 3.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $998.0M $1.013B
YoY Change
Total Liabilities & Shareholders Equity $1.740B $1.756B
YoY Change -6.94% -7.91%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$22.69M -$36.85M
YoY Change -45.67% 81.11%
Depreciation, Depletion And Amortization $18.07M $17.46M
YoY Change 7.14% 4.88%
Cash From Operating Activities -$3.685M -$16.27M
YoY Change -81.37% 109.5%
INVESTING ACTIVITIES
Capital Expenditures $4.534M -$7.844M
YoY Change -137.82% -47.63%
Acquisitions
YoY Change
Other Investing Activities $3.471M $3.646M
YoY Change 44.38% 1152.92%
Cash From Investing Activities -$1.063M -$4.198M
YoY Change -88.91% -71.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.802M 2.959M
YoY Change -26.75% -144.03%
NET CHANGE
Cash From Operating Activities -3.685M -16.27M
Cash From Investing Activities -1.063M -4.198M
Cash From Financing Activities 1.802M 2.959M
Net Change In Cash -2.946M -17.51M
YoY Change -89.05% -39.98%
FREE CASH FLOW
Cash From Operating Activities -$3.685M -$16.27M
Capital Expenditures $4.534M -$7.844M
Free Cash Flow -$8.219M -$8.428M
YoY Change 5.52% -216.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001077183
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35756
dei Entity Registrant Name
EntityRegistrantName
NEOGENOMICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-2897368
dei Entity Address Address Line1
EntityAddressAddressLine1
9490 NeoGenomics Way,
dei Entity Address City Or Town
EntityAddressCityOrTown
Fort Myers,
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33912
dei City Area Code
CityAreaCode
(239)
dei Local Phone Number
LocalPhoneNumber
768-0600
dei Security12b Title
Security12bTitle
Common stock ($0.001 par value)
dei Trading Symbol
TradingSymbol
NEO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
198563000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
111994000 usd
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
126303261 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266126000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
316827000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
177414000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
112130000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
23799000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
23395000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
16511000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12354000 usd
CY2022Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
0 usd
CY2021Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
10050000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
7516000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8189000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
603360000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
681508000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
125018000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
109952000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
106818000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
109465000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
98945000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
102197000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
416848000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
442325000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
522766000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
527115000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6845000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7168000 usd
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
20420000 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1152222000 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1188270000 usd
CY2022Q3 us-gaap Assets
Assets
1755582000 usd
CY2021Q4 us-gaap Assets
Assets
1869778000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
13708000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
17921000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
37992000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
38304000 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
17796000 usd
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
118000 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1135000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6379000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6884000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6386000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5192000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
85003000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
87232000 usd
CY2022Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
534609000 usd
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
532483000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
70471000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
72289000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
38345000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
55475000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14166000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14022000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
657591000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
674269000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
742594000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
761501000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14837000 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126562037 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126562037 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
124107500 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
124107500 shares
CY2022Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
127000 usd
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
124000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1154365000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1123628000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5104000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-638000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-136400000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
358597000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1012988000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1108277000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1755582000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1869778000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
128782000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
121340000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
371023000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
79889000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
74101000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
239952000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
216794000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
48893000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
47239000 usd
us-gaap Gross Profit
GrossProfit
131071000 usd
us-gaap Gross Profit
GrossProfit
141803000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64282000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
63839000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
188481000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
158953000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7312000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7409000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23651000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13360000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16809000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15704000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
50179000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
46677000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
88403000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
86952000 usd
us-gaap Operating Expenses
OperatingExpenses
262311000 usd
us-gaap Operating Expenses
OperatingExpenses
218990000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-39510000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.17
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-39713000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-131240000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-77187000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
139000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
1296000 usd
us-gaap Interest Expense
InterestExpense
2366000 usd
us-gaap Interest Expense
InterestExpense
3375000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
89000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-212000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
431000 usd
CY2022Q3 neo Gain Loss On Investment And Loan Receivable
GainLossOnInvestmentAndLoanReceivable
0 usd
CY2021Q3 neo Gain Loss On Investment And Loan Receivable
GainLossOnInvestmentAndLoanReceivable
17750000 usd
neo Gain Loss On Investment And Loan Receivable
GainLossOnInvestmentAndLoanReceivable
0 usd
neo Gain Loss On Investment And Loan Receivable
GainLossOnInvestmentAndLoanReceivable
109260000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39624000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23170000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-133818000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29129000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2772000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2822000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12255000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4283000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-36852000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-20348000 usd
us-gaap Net Income Loss
NetIncomeLoss
-121563000 usd
us-gaap Net Income Loss
NetIncomeLoss
33412000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.30
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.17
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.98
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.28
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.30
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.98
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.28
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124425000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122559000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124055000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119087000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124425000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122559000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124055000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121356000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-36852000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-20348000 usd
us-gaap Net Income Loss
NetIncomeLoss
-121563000 usd
us-gaap Net Income Loss
NetIncomeLoss
33412000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1048000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-57000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4466000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-400000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1048000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-57000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4466000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-400000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37900000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20405000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-126029000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33012000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1108277000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
971000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1049000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6480000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
249000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11855000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2371000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-49408000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1075004000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
807000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-310000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
743000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
293000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3332000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1047000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-35303000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1043519000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1133000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-5000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1961000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
257000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4023000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1048000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-36852000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1012988000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
694294000 usd
CY2021Q1 neo Adjustments To Additional Paid In Capital Decrease From Purchase Of Calls Related To Convertible Debt
AdjustmentsToAdditionalPaidInCapitalDecreaseFromPurchaseOfCallsRelatedToConvertibleDebt
29291000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1024000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-614000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2239000 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
218500000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
242000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
241000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2412000 usd
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-160000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-22114000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
843714000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1245000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-163000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4430000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1137245000 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
189863000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
29175000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
102000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
298000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4208000 usd
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-183000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
75873000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1148358000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1020000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-304000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3374000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
35000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
236000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5001000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-57000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-20348000 usd
neo Receivable With Imputed Interest Non Consolidated Affiliates
ReceivableWithImputedInterestNonConsolidatedAffiliates
391000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-3066000 usd
us-gaap Net Income Loss
NetIncomeLoss
-121563000 usd
us-gaap Net Income Loss
NetIncomeLoss
33412000 usd
us-gaap Depreciation
Depreciation
25894000 usd
us-gaap Depreciation
Depreciation
21807000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25470000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14683000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
20009000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
12396000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
7375000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
6167000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1989000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1904000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
136000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
133000 usd
neo Gain On Investment In And Loan Receivable From Non Consolidated Affiliate Net
GainOnInvestmentInAndLoanReceivableFromNonConsolidatedAffiliateNet
0 usd
neo Gain On Investment In And Loan Receivable From Non Consolidated Affiliate Net
GainOnInvestmentInAndLoanReceivableFromNonConsolidatedAffiliateNet
109260000 usd
neo Receivable With Imputed Interest Non Consolidated Affiliates
ReceivableWithImputedInterestNonConsolidatedAffiliates
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-166000 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
2048000 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
neo Polymerase Chain Reaction Testing Exit Costs Covid19
PolymeraseChainReactionTestingExitCostsCOVID19
0 usd
neo Polymerase Chain Reaction Testing Exit Costs Covid19
PolymeraseChainReactionTestingExitCostsCOVID19
6061000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1428000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1222000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-136000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2475000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
403000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3196000 usd
neo Increase Decrease In Prepaid Construction
IncreaseDecreaseInPrepaidConstruction
0 usd
neo Increase Decrease In Prepaid Construction
IncreaseDecreaseInPrepaidConstruction
4435000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3605000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11796000 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-20192000 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
15313000 usd
neo Repayments Of Equipment And Other Finance Obligation
RepaymentsOfEquipmentAndOtherFinanceObligation
706000 usd
neo Repayments Of Equipment And Other Finance Obligation
RepaymentsOfEquipmentAndOtherFinanceObligation
2537000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62308000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6947000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
73973000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
180961000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
89812000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
44736000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26357000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
52155000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
12098000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
419404000 usd
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
0 usd
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
15000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1580000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-622784000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10733000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12110000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
334410000 usd
neo Payments Of Premiums For Capped Call Confirmations
PaymentsOfPremiumsForCappedCallConfirmations
0 usd
neo Payments Of Premiums For Capped Call Confirmations
PaymentsOfPremiumsForCappedCallConfirmations
29291000 usd
neo Proceeds From Equity Offering Net
ProceedsFromEquityOfferingNet
0 usd
neo Proceeds From Equity Offering Net
ProceedsFromEquityOfferingNet
408133000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10027000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
722825000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-50701000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
93094000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
316827000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250632000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
266126000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
343726000 usd
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266126000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
340565000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3161000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
266126000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
343726000 usd
us-gaap Interest Paid Net
InterestPaidNet
2145000 usd
us-gaap Interest Paid Net
InterestPaidNet
1792000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
155000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
113000 usd
neo Fair Value Of Common Stock Issued To Fund Acquisition
FairValueOfCommonStockIssuedToFundAcquisition
0 usd
neo Fair Value Of Common Stock Issued To Fund Acquisition
FairValueOfCommonStockIssuedToFundAcquisition
29174000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1144000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2184000 usd
CY2021Q1 neo Polymerase Chain Reaction Testing Exit Costs Covid19
PolymeraseChainReactionTestingExitCostsCOVID19
6100000 usd
CY2021Q1 neo Polymerase Chain Reaction Testing Write Offs Covid19
PolymeraseChainReactionTestingWriteOffsCOVID19
5300000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
12100000 usd
CY2021Q1 neo Polymerase Chain Reaction Testing General And Administrative Expenses Covid19
PolymeraseChainReactionTestingGeneralAndAdministrativeExpensesCOVID19
800000 usd
neo Polymerase Chain Reaction Testing General And Administrative Expenses Covid19
PolymeraseChainReactionTestingGeneralAndAdministrativeExpensesCOVID19
0 usd
CY2021Q3 neo Polymerase Chain Reaction Testing General And Administrative Expenses Covid19
PolymeraseChainReactionTestingGeneralAndAdministrativeExpensesCOVID19
0 usd
CY2022Q3 neo Polymerase Chain Reaction Testing General And Administrative Expenses Covid19
PolymeraseChainReactionTestingGeneralAndAdministrativeExpensesCOVID19
0 usd
CY2022Q3 neo Social Security Tax Employer Deferral Cares Act
SocialSecurityTaxEmployerDeferralCARESAct
3000000 usd
CY2021Q4 neo Social Security Tax Employer Deferral Cares Act
SocialSecurityTaxEmployerDeferralCARESAct
3000000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares its Consolidated Financial Statements in conformity with GAAP. These principles require management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the Consolidated Financial Statements. Actual results and outcomes may differ from management’s estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these Consolidated Financial Statements include, but are not limited, to those related to revenues, accounts receivable and related allowances, contingencies, useful lives and recovery of long-term assets and intangible assets, income taxes and valuation allowances, stock-based compensation, business combinations, and impairment analysis of goodwill. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected on the Consolidated Financial Statements prospectively from the date of the change in estimate.</span></div>
CY2022Q3 neo Asset Held For Sale Square Feet Of Facility Owned
AssetHeldForSaleSquareFeetOfFacilityOwned
43560 sqft
CY2021Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
10100000 usd
CY2022Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Current
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent
182782000 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5368000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
177414000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Current
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent
199464000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
22000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
923000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
198563000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
700000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
600000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
112167000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
65247000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
0 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
177414000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
104711000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
93852000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
0 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
198563000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
527115000 usd
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-4349000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
522766000 usd
CY2022Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
501380000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
84532000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
416848000 usd
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
501380000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
59055000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
442325000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8490000 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8474000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25470000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14683000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8490000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
33962000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
33961000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
33858000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
33547000 usd
CY2022Q3 neo Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
259583000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
403401000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4300000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5200000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12400000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2961195 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3849603 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.94
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
804555 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.35
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1758886 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
28.75
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4247357 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.23
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1019075 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
24.91
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
6.51
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
14800000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2021Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
882000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
Collection of consideration the Company expects to receive typically occurs within 90 to 120 days of billing for commercial insurance, Medicare and other governmental and self-pay payers and within 60 to 90 days of billing for client payers.
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2679000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1738000 usd
CY2022Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
257000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
236000 usd
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
2936000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1974000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
106000 usd
CY2021Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
109000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1527000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Gross
CapitalizedContractCostGross
1633000 usd
CY2021Q4 us-gaap Capitalized Contract Cost Gross
CapitalizedContractCostGross
991000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6386000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5192000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1128000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
917000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7514000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6109000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
700000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4800000 usd
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4200000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
300000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
600000 usd
CY2021Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
200000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
900000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
128782000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
121340000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
371023000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
358597000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36852000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20348000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-121563000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
33412000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
124425000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
122559000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
124055000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
119087000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124425000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122559000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124055000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121356000 shares
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.30
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.17
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.98
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.28
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.30
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.17
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.98
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.28
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
128782000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
121340000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
371023000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
358597000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
79889000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
74101000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
239952000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
216794000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
48893000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
47239000 usd
us-gaap Gross Profit
GrossProfit
131071000 usd
us-gaap Gross Profit
GrossProfit
141803000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64282000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
63839000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
188481000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
158953000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7312000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7409000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23651000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13360000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16809000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15704000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
50179000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
46677000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
88403000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
86952000 usd
us-gaap Operating Expenses
OperatingExpenses
262311000 usd
us-gaap Operating Expenses
OperatingExpenses
218990000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-39510000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-39713000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-131240000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-77187000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
139000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
1296000 usd
us-gaap Interest Expense
InterestExpense
2366000 usd
us-gaap Interest Expense
InterestExpense
3375000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
89000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-212000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
431000 usd
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2021Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
17750000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
109260000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39624000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23170000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-133818000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29129000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2772000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2822000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12255000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4283000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-36852000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-20348000 usd
us-gaap Net Income Loss
NetIncomeLoss
-121563000 usd
us-gaap Net Income Loss
NetIncomeLoss
33412000 usd

Files In Submission

Name View Source Status
neo-20220930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
0001077183-22-000173-index-headers.html Edgar Link pending
0001077183-22-000173-index.html Edgar Link pending
0001077183-22-000173.txt Edgar Link pending
0001077183-22-000173-xbrl.zip Edgar Link pending
a09302022neo-ex311.htm Edgar Link pending
a09302022neo-ex312.htm Edgar Link pending
a09302022neo-ex321.htm Edgar Link pending
a10-1retentionagreementcin.htm Edgar Link pending
a10-2amendedemploymentagre.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
image_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
neo-20220930.htm Edgar Link pending
neo-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
neo-20220930_cal.xml Edgar Link unprocessable
neo-20220930_def.xml Edgar Link unprocessable
neo-20220930_lab.xml Edgar Link unprocessable
neo-20220930_pre.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending